We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Wayfair
W
$13.7B
| $26.3M | 0.04% |
285,000
-48,000
| -14% | -$3.54M |
|
427
Huntington Bancshares
HBAN
$33.6B
| $26.3M | 0.04% |
1,481,535
-161,700
| -10% | -$2.67M |
|
428
Casey's General Stores
CASY
$23.2B
| $26.1M | 0.04% |
+32,900
| New | +$26.5M |
|
429
Snowflake
SNOW
$117B
| $26.1M | 0.04% |
102,500
-12,500
| -11% | -$2.3M |
|
430
Marriott International
MAR
$86.4B
| $26M | 0.04% |
70,025
-127,000
| -64% | -$46.8M |
|
431
Atmos Energy
ATO
$28.2B
| $25.6M | 0.04% |
+148,804
| New | +$26.6M |
|
432
Flex
FLEX
$41.6B
| $25.6M | 0.04% |
+157,700
| New | +$19.1M |
|
433
Sabra Healthcare REIT
SBRA
$5.31B
| $25.4M | 0.04% |
1,300,000
+150,000
| +13% | +$2.98M |
|
434
Essential Utilities
WTRG
$11.9B
| $25.3M | 0.04% |
661,098
+93,299
| +16% | +$3.56M |
|
435
Samsara
IOT
$22.6B
| $25.2M | 0.04% |
777,777
+202,777
| +35% | +$6.28M |
|
436
SAB Biotherapeutics
SABS
$317M
| $25M | 0.04% |
6,405,553
+3,000,000
| +88% | +$11.2M |
|
437
Globe Life
GL
$13.1B
| $24.9M | 0.03% |
139,200
+68,200
| +96% | +$10.7M |
|
|
IRD
438
Opus Genetics
IRD
$477M
| $24.8M | 0.03% |
6,029,775
| – | – |
|
|
KRAQ
439
KRAKacquisition Corp
KRAQ
$433M
| $24.8M | 0.03% |
2,475,000
| – | – |
|
440
Cousins Properties
CUZ
$4.59B
| $24.7M | 0.03% |
825,000
-43,750
| -5% | -$1.15M |
|
441
Fair Isaac
FICO
$21.2B
| $24.7M | 0.03% |
20,700
-500
| -2% | -$560K |
|
442
Edison International
EIX
$22.1B
| $24.5M | 0.03% |
328,904
+12,200
| +4% | +$870K |
|
443
Allison Transmission
ALSN
$10.6B
| $24.2M | 0.03% |
215,000
+135,000
| +169% | +$16.4M |
|
|
MEVO
444
M Evo Global Acquisition Corp II
MEVO
$401M
| $24.1M | 0.03% |
2,430,000
| – | – |
|
445
BrightSpring Health Services
BTSG
$12.3B
| $24.1M | 0.03% |
345,000
+305,270
| +768% | +$17M |
|
446
FormFactor
FORM
$8.92B
| $24M | 0.03% |
+150,000
| New | +$19.9M |
|
447
Nutrien
NTR
$38.5B
| $23.9M | 0.03% |
380,000
+160,000
| +73% | +$11.2M |
|
448
Remitly
RELY
$5.1B
| $23.6M | 0.03% |
1,055,000
-1,655,000
| -61% | -$33.9M |
|
449
Advanced Drainage Systems
WMS
$9.94B
| $23.5M | 0.03% |
150,000
-400,000
| -73% | -$57.2M |
|
|
DRUG
450
Bright Minds Biosciences
DRUG
$638M
| $23.5M | 0.03% |
335,000
-160,743
| -32% | -$12.6M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.